MDAI Spectral AI, Inc.

P/E --

Forward P/E 52.36

Price/Sales 3.646

Beta 1.158

Div Yield --

Market Cap --

Company Analysis

Latest News

June 05, 2026

Spectral AI Details 2026 Commercial Launch Plan Following FDA DeepView System Clearance

Spectral AI (MDAI) announced its strategic outlook and commercialization plan after receiving FDA De Novo Classification for its DeepView® System for burn...